Interpharm Laboratories Ltd. Names Cameron Reid Chief Executive Officer; Former Dr. Reddy's Laboratories Limited's (RDY) President To Focus On Strategic Growth Initiatives
10/19/2005 5:12:32 PM
COMMACK, N.Y.--(BUSINESS WIRE)--Jan. 25, 2005--Interpharm Holdings, Inc. (AMEX: IPA), today announced the appointment of Cameron Reid as its Chief Executive Officer. In order to focus on his responsibilities as Chief Executive Officer, Mr. Reid has resigned his position as Director. Dr. Maganlal K. Sutaria, who has served as Chairman of the Board and Chief Executive Officer for fifteen years, will continue in his role as Chairman.
comments powered by